Optimization of prednisolone-loaded long-circulating liposomes via application of Quality by Design (QbD) approach

Abstract

Quality by design principles (QbD) were used to assist the formulation of prednisolone-loaded long-circulating liposomes (LCL-PLP) in order to gain a more comprehensive understanding of the preparation process. This approach enables us to improve the final product quality in terms of liposomal drug concentration, encapsulation efficiency and size, and to minimize preparation variability. A 19-run D-optimal experimental design was used to study the impact of the highest risk factors on PLP liposomal concentration (Y₁- μg/ml), encapsulation efficiency (Y₂-%) and size (Y₃-nm). Out of six investigated factors, four of them were identified as critical parameters affecting the studied responses. PLP molar concentration and the molar ratio of DPPC to MPEG-2000-DSPE had a positive impact on both Y₁ and Y₂, while the rotation speed at the formation of the lipid film had a negative impact. Y₃ was highly influenced by prednisolone molar concentration and extrusion temperature. The accuracy and robustness of the model was further on confirmed. The developed model was used to optimize the formulation of LCL-PLP for efficient accumulation of the drug to tumor tissue. The cytotoxicity of the optimized LCL-PLP on C26 murine colon carcinoma cells was assessed. LCL-PLP exerted significant anti-angiogenic and anti-inflammatory effects on M2 macrophages, affecting indirectly the C26 colon carcinoma cell proliferation and development.

Keywords:

• Design space
• drug targeting
• PEGylated liposomes
• prednisolone
• QbD

Declaration of interest

The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article.

This work was supported by a grant of the Romanian National Authority for Scientific Research, CNDI– UEFISCDI, project number PN-II-PT-PCCA-2011–3.2–1060.